Events

Events Search and Views Navigation

Event Views Navigation

Today

  • Swiss Nordic Bio 2021

    Ascelia Pharma presents at the investor seminar Swiss Nordic Bio. All information about the event and how to book meetings can be found on https://swissnordicbio.com/  

  • Swiss Nordic Bio 2021

    Ascelia Pharma presents at the investor seminar Swiss Nordic Bio. All information about the event and how to book meetings can be found on https://swissnordicbio.com/  

  • Full-year financial report 2020 (Jan-Dec)

    Report will be released at 8.00am CET and conference call at 10.00 am CET. Info about conference call/webcast: Ascelia Pharma, Audiocast with teleconference, Q4, 2020 | Financial Hearings  

  • Full-year financial report 2020 (Jan-Dec)

    Report will be released at 8.00am CET and conference call at 10.00 am CET. Info about conference call/webcast: Ascelia Pharma, Audiocast with teleconference, Q4, 2020 | Financial Hearings  

  • Life Science Investor conference

    Magnus Corfitzen, Ascelia Pharma's CEO will be presenting at the Life Science Conference at 16:50 CET.  Link to this virtual event is: Events - Life Science | Økonomisk Ugebrev  

  • Life Science Investor conference

    Magnus Corfitzen, Ascelia Pharma's CEO will be presenting at the Life Science Conference at 16:50 CET.  Link to this virtual event is: Events - Life Science | Økonomisk Ugebrev  

  • HC Andersen Capital Event

    Julie Waras Brogren, Chief Commercial Officer at Ascelia Pharma will present at HC Andersen Capital event. The topic will be: 'Mangoral market potential and plans for commercialization’ To register to the event: https://hcandersencapital643.clickmeeting.com/ascelia-pharma-mangoral-markedsstorrelse-og-potentiale/register

  • HC Andersen Capital Event

    Julie Waras Brogren, Chief Commercial Officer at Ascelia Pharma will present at HC Andersen Capital event. The topic will be: 'Mangoral market potential and plans for commercialization’ To register to the event: https://hcandersencapital643.clickmeeting.com/ascelia-pharma-mangoral-markedsstorrelse-og-potentiale/register

  • Redeye Orphan Drugs Seminar – April 2021

    Ascelia Pharma's Chief Medical Officer, Carl Bjartmar will present at Redeye Orphan Drugs Seminar. The presentation will be live streamed, to register to the event: https://www.redeye.se/events/802433/theme-orphan-apr-28th

  • Redeye Orphan Drugs Seminar – April 2021

    Ascelia Pharma's Chief Medical Officer, Carl Bjartmar will present at Redeye Orphan Drugs Seminar. The presentation will be live streamed, to register to the event: https://www.redeye.se/events/802433/theme-orphan-apr-28th